Looking for a breakdown of NCQA's changes for HEDIS Measurement Year 2022? Catch up on our most recent blog post here.
The National Committee for Quality Assurance (NCQA) is accepting comments through March 13 on proposed changes for next year’s HEDIS® season, Measurement Year 2020 (MY 2020), from health plans and other stakeholders. Jamison Gillitzer, product manager for Cotiviti’s quality improvement solutions, summarizes the important details for plans that report HEDIS data.
Changes to existing measures
NCQA is proposing several changes to measures related to well-child visits, high-risk medication use, and depression screening, among many others.
Measure Name |
Summary of Proposed Changes |
---|---|
Well-Child Visits in the First 15 Months of Life (W15) |
|
Well-Child Visits in the Third, Fourth, Fifth and Sixth Years of Life (W34)
Adolescent Well-Care Visits (AWC) |
|
Emergency Department Utilization (EDU) |
|
Use of High-Risk Medications in Older Adults (DAE) |
|
Transitions of Care (TRC) |
|
Controlling High Blood Pressure (CBP) |
|
Follow-Up After Hospitalization for Mental Illness (FUH) |
|
Adult Immunization Status (AIS) |
|
Unhealthy Alcohol Use Screening and Follow-Up (ASF) |
|
Depression Screening and Follow-Up for Adolescents and Adults (DSF) Prenatal Depression Screening and Follow-Up (PND) Postpartum Depression Screening and Follow-Up (PDS)
|
|
New measures being introduced
NCQA proposes three new measures for MY 2020, two of which replace measures being retired.
Measure Name |
Description |
---|---|
Cardiac Rehabilitation (CRE) |
“The percentage of members 18 years and older who attended cardiac rehabilitation following a qualifying cardiac event, including myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft, heart and heart/lung transplantation or heart valve repair/replacement.” This includes three rates:
|
Kidney Health Evaluation for Patients with Diabetes (KED) |
“The percentage of members 18–75 years of age with diabetes (type 1 and type 2) who received a kidney health evaluation, defined by an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR), during the measurement year.” Replaces Comprehensive Diabetes Care (CDC)–Medical Attention for Nephropathy. |
Osteoporosis Screening in Older Women (OSW) |
“The percentage of women 65–75 years of age who are screened for osteoporosis.” Replaces Osteoporosis Testing in Older Women (OTO). |
Measures being retired
NCQA proposed to retire four measures and two measure indicators for Comprehensive Diabetes Care (CDC). These retirements would be effective MY 2020 with the exception of Annual Dental Visit (ADV), which would not be effective until MY 2022.
Measure Name |
Rationale for Retiring Measure |
---|---|
Annual Dental Visit (ADV) |
|
Adult BMI Assessment (ABA) |
|
Medication Management for People with Asthma (MMA) |
|
Children and Adolescents’ Access to Primary Care Practitioners (CAP) |
|
Comprehensive Diabetes Care (CDC)–Medical Attention for Nephropathy indicator |
|
Comprehensive Diabetes Care (CDC)–HbA1c Control (<7.0%) for a Selected Population indicator |
|
Cross-cutting exclusion
Noting that “quality measures designed for a general population may not be clinically appropriate or a priority” for those receiving palliative care, including certain opioid measures, NCQA proposes to exclude members receiving palliative care across the following 13 measures:
- Risk of Continued Opioid Use
- Use of Opioids at High Dosage
- Potentially Harmful Drug Interactions in Older Adults
- Use of High-Risk Medications in Older Adults
- Breast Cancer Screening
- Cervical Cancer Screening
- Colorectal Cancer Screening
- Osteoporosis Screening in Older Women
- Comprehensive Diabetes Care
- Controlling High Blood Pressure
- Osteoporosis Management in Women Who Had a Fracture
- Statin Therapy for Patients With Cardiovascular Disease
- Statin Therapy for Patients With Diabetes
Health Plan Descriptive measures
With the goal of “simplifying reporting and reducing undue customer burden while ensuring that reported data is meaningful,” NCQA is seeking public comment on the value of these six descriptive measures:
- Enrollment by Product Line (ENP)
- Enrollment by State (EBS)
- Language Diversity of Membership (LDM)
- Race/Ethnicity Diversity of Membership (RDM)
- Total Membership (TLM)
- Board Certification (BCR)
NCQA asks health plans to offer input on whether they use them for their own accountability, quality improvement, or payment initiatives, and which measures are useful.
Timeline changes
While NCQA is not seeking public comment on these changes, the organization is shifting two dates in its annual publication and certification deadline schedule to release complete measure specifications nearly a full year earlier than its previous schedule, as summarized below. In tandem with these changes, vendors will now have more time between when specifications are released and the final certification deadline.
Item |
MY 2020 Release Date (current year) |
MY 2021 Release Date (transition year) |
MY 2022 Release Date (future years) |
---|---|---|---|
Volume 1 (Narrative) and Volume 2 (Technical Specifications) |
July 1, 2020 |
July 1, 2020 (combined with MY 2020) |
August 1, 2021 |
Volume 2 Technical Update |
October 1, 2020 |
March 31, 2021 |
March 31, 2022 |
Vendor Certification |
February 15, 2021 |
October 1, 2021 |
July 1, 2022 |
Time to comment
Ready to weigh in? Read NCQA’s full description of all proposed changes and follow the directions on this page by 11:59 pm ET on Friday, March 13, 2020.
How does the HEDIS software measure certification process work, and how does it impact a health plan's processes when a vendor has to recertify mid-season? Watch our recent video as we explain the basics of the HEDIS certification and recertification processes—and Cotiviti's approach to minimizing recertifications.
HEDIS® is a registered trademark of the National Committee for Quality Assurance.